|
1
|
Goldring SR: The role of bone in
osteoarthritis pathogenesis. Rheum Dis Clin North Am. 34:561–571.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sofat N, Ejindu V and Kiely P: What makes
osteoarthritis painful? The evidence for local and central pain
processing. Rheumatology (Oxford). 50:2157–2165. 2011. View Article : Google Scholar
|
|
3
|
Man GS and Mologhianu G: Osteoarthritis
pathogenesis - a complex process that involves the entire joint. J
Med Life. 7:37–41. 2014.PubMed/NCBI
|
|
4
|
Scanzello CR, Plaas A and Crow MK: Innate
immune system activation in osteoarthritis: is osteoarthritis a
chronic wound? Curr Opin Rheumatol. 20:565–572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ting JP, Duncan JA and Lei Y: How the
noninflammasome NLRs function in the innate immune system. Science.
327:286–290. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McCormack WJ, Parker AE and O'Neill LA:
Toll-like receptors and NOD-like receptors in rheumatic diseases.
Arthritis Res Ther. 11:2432009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haglund L, Bernier SM, Onnerfjord P and
Recklies AD: Proteomic analysis of the LPS-induced stress response
in rat chondrocytes reveals induction of innate immune response
components in articular cartilage. Matrix Biol. 27:107–118. 2008.
View Article : Google Scholar
|
|
8
|
Schelbergen RF, Blom AB, van den Bosch MH,
Slöetjes A, Abdollahi-Roodsaz S, Schreurs BW, Mort JS, Vogl T, Roth
J, van den Berg WB and van Lent PL: Alarmins S100A8 and S100A9
elicit a catabolic effect in human osteoarthritic chondrocytes that
is dependent on Toll-like receptor 4. Arthritis Rheum.
64:1477–1487. 2012. View Article : Google Scholar
|
|
9
|
Abdollahi-Roodsaz S, Joosten LA, Roelofs
MF, Radstake TR, Matera G, Popa C, van der Meer JW, Netea MG and
van den Berg WB: Inhibition of Toll-like receptor 4 breaks the
inflammatory loop in autoimmune destructive arthritis. Arthritis
Rheum. 56:2957–2967. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shotorbani SS, Su ZL and Xu HX: Toll-like
receptors are potential therapeutic targets in rheumatoid
arthritis. World J Biol Chem. 2:167–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bobacz K, Sunk IG, Hofstaetter JG, Amoyo
L, Toma CD, Akira S, Weichhart T, Saemann M and Smolen JS:
Toll-like receptors and chondrocytes: the
lipopolysaccharide-induced decrease in cartilage matrix synthesis
is dependent on the presence of toll-like receptor 4 and
antagonized by bone morphogenetic protein 7. Arthritis Rheum.
56:1880–1893. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sgaglione NA: Biologic approaches to
articular cartilage surgery: future trends. Orthop Clin North Am.
36:485–495. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Im HJ, Li X, Chen D, Yan D, Kim J, Ellman
MB, Stein GS, Cole B, Kc R, Cs-Szabo G and van Wijnen AJ:
Biological effects of the plant-derived polyphenol resveratrol in
human articular cartilage and chondrosarcoma cells. J Cell Physiol.
227:3488–3497. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yadav M, Jain S, Bhardwaj A, Nagpal R,
Puniya M, Tomar R, Singh V, Parkash O, Prasad GB, Marotta F and
Yadav H: Biological and medicinal properties of grapes and their
bioactive constituents: an update. J Med Food. 12:473–484. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eo SH, Cho H and Kim SJ: Resveratrol
inhibits nitric oxide-induced apoptosis via the NF-kappa B pathway
in rabbit articular chondrocytes. Biomol Ther (Seoul). 21:364–370.
2013. View Article : Google Scholar
|
|
16
|
Csaki C, Keshishzadeh N, Fischer K and
Shakibaei M: Regulation of inflammation signalling by resveratrol
in human chondrocytes in vitro. Biochem Pharmacol. 75:677–687.
2008. View Article : Google Scholar
|
|
17
|
Shakibaei M, John T, Seifarth C and
Mobasheri A: Resveratrol inhibits IL-1 beta-induced stimulation of
caspase-3 and cleavage of PARP in human articular chondrocytes in
vitro. Ann N Y Acad Sci. 1095:554–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Elmali N, Esenkaya I, Harma A, Ertem K,
Turkoz Y and Mizrak B: Effect of resveratrol in experimental
osteoarthritis in rabbits. Inflamm Res. 54:158–162. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Elmali N, Baysal O, Harma A, Esenkaya I
and Mizrak B: Effects of resveratrol in inflammatory arthritis.
Inflammation. 30:1–6. 2007. View Article : Google Scholar
|
|
20
|
Lei M, Wang JG, Xiao DM, Fan M, Wang DP,
Xiong JY, Chen Y, Ding Y and Liu SL: Resveratrol inhibits
interleukin 1β-mediated inducible nitric oxide synthase expression
in articular chondrocytes by activating SIRT1 and thereby
suppressing nuclear factor-κB activity. Eur J Pharmacol. 674:73–79.
2012. View Article : Google Scholar
|
|
21
|
Shakibaei M, Mobasheri A and Buhrmann C:
Curcumin synergizes with resveratrol to stimulate the MAPK
signaling pathway in human articular chondrocytes in vitro. Genes
Nutr. 6:171–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eo SH, Cho HS and Kim SJ: Resveratrol
regulates type II collagen and COX-2 expression via the ERK, p38
and Akt signaling pathways in rabbit articular chondrocytes. Exp
Ther Med. 7:640–648. 2014.PubMed/NCBI
|
|
23
|
Han KJ, Su X, Xu LG, Bin LH, Zhang J and
Shu HB: Mechanisms of the TRIF-induced interferon-stimulated
response element and NF-kappaB activation and apoptosis pathways. J
Biol Chem. 279:15652–15661. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Baumgarten G, Knuefermann P, Nozaki N,
Sivasubramanian N, Mann DL and Vallejo JG: In vivo expression of
proinflammatory mediators in the adult heart after endotoxin
administration: the role of toll-like receptor-4. J Infect Dis.
183:1617–1624. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jakus PB, Kalman N, Antus C, Radnai B,
Tucsek Z, Gallyas F Jr, Sumegi B and Veres B: TRAF6 is functional
in inhibition of TLR4-mediated NF-κB activation by resveratrol. J
Nutr Biochem. 24:819–823. 2013. View Article : Google Scholar
|
|
26
|
Liu L, Gu H, Liu H, Jiao Y, Li K, Zhao Y,
An L and Yang J: Protective effect of resveratrol against
IL-1β-induced inflammatory response on human osteoarthritic
chondrocytes partly via the TLR4/MyD88/NF-κB signaling pathway: an
'in vitro study'. Int J Mol Sci. 15:6925–6940. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sebai H, Ristorcelli E, Sbarra V,
Hovsepian S, Fayet G, Aouani E and Lombardo D: Protective effect of
resveratrol against LPS-induced extracellular lipoperoxidation in
AR42J cells partly via a Myd88-dependent signaling pathway. Arch
Biochem Biophys. 495:56–61. 2010. View Article : Google Scholar
|
|
28
|
Jung DY, Lee H, Jung BY, Ock J, Lee MS,
Lee WH and Suk K: TLR4, but not TLR2, signals autoregulatory
apoptosis of cultured microglia: a critical role of IFN-beta as a
decision maker. J Immunol. 174:6467–6476. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
30
|
Vincenti MP and Brinckerhoff CE:
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in
arthritis: integration of complex signaling pathways for the
recruitment of gene-specific transcription factors. Arthritis Res.
4:157–164. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yammani RR, Carlson CS, Bresnick AR and
Loeser RF: Increase in production of matrix metalloproteinase 13 by
human articular chondrocytes due to stimulation with S100A4: role
of the receptor for advanced glycation end products. Arthritis
Rheum. 54:2901–2911. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Im HJ, Pacione C, Chubinskaya S, Van
Wijnen AJ, Sun Y and Loeser RF: Inhibitory effects of insulin-like
growth factor-1 and osteogenic protein-1 on fibronectin fragment-
and interleukin-1beta-stimulated matrix metalloproteinase-13
expression in human chondrocytes. J Biol Chem. 278:25386–25394.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Muddasani P, Norman JC, Ellman M, van
Wijnen AJ and Im HJ: Basic fibroblast growth factor activates the
MAPK and NFkappaB pathways that converge on Elk-1 to control
production of matrix metalloproteinase-13 by human adult articular
chondrocytes. J Biol Chem. 282:31409–31421. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Legendre F, Bogdanowicz P, Boumediene K
and Pujol JP: Role of interleukin 6 (IL-6)/IL-6R-induced signal
tranducers and activators of transcription and mitogen-activated
protein kinase/extracellular. J Rheumatol. 32:1307–1316.
2005.PubMed/NCBI
|
|
35
|
Estrov Z, Shishodia S, Faderl S, Harris D,
Van Q, Kantarjian HM, Talpaz M and Aggarwal BB: Resveratrol blocks
interleukin-1beta-induced activation of the nuclear transcription
factor NF-kappaB, inhibits proliferation, causes S-phase arrest,
and induces apoptosis of acute myeloid leukemia cells. Blood.
102:987–995. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kundu JK, Shin YK and Surh YJ: Resveratrol
modulates phorbol ester-induced pro-inflammatory signal
transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as
prime targets. Biochem Pharmacol. 72:1506–1515. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu-Bryan R and Terkeltaub R: Chondrocyte
innate immune myeloid differentiation factor 88-dependent signaling
drives procatabolic effects of the endogenous Toll-like receptor
2/Toll-like receptor 4 ligands low molecular weight hyaluronan and
high mobility group box chromosomal protein 1 in mice. Arthritis
Rheum. 62:2004–2012. 2010.PubMed/NCBI
|
|
38
|
Weighardt H, Jusek G, Mages J, Lang R,
Hoebe K, Beutler B and Holzmann B: Identification of a TLR4- and
TRIF-dependent activation program of dendritic cells. Eur J
Immunol. 34:558–564. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Björkbacka H, Fitzgerald KA, Huet F, Li X,
Gregory JA, Lee MA, Ordija CM, Dowley NE, Golenbock DT and Freeman
MW: The induction of macrophage gene expression by LPS
predominantly utilizes Myd88-independent signaling cascades.
Physiol Genomics. 19:319–330. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang Z, Mak TW, Sen G and Li X: Toll-like
receptor 3-mediated activation of NF-kappaB and IRF3 diverges at
Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Proc Natl Acad Sci USA. 101:3533–3538. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sato S, Sugiyama M, Yamamoto M, Watanabe
Y, Kawai T, Takeda K and Akira S: Toll/IL-1 receptor
domain-containing adaptor inducing IFN-beta (TRIF) associates with
TNF receptor-associated factor 6 and TANK-binding kinase 1, and
activates two distinct transcription factors, NF-kappa B and
IFN-regulatory factor-3, in the Toll-like receptor signaling. J
Immunol. 171:4304–4310. 2003. View Article : Google Scholar : PubMed/NCBI
|
